NuView Life Sciences was recently asked to manage the future growth of Trace Life Sciences. In accepting the challenge, we began by identifying the necessary changes for the business itself to become more efficient. We started by talking with our employees and by introducing a new corporate culture, for all to understand and stimulate the need for the Company to compete effectively by providing value driven products.

In carefully listening to the needs of the marketplace, professionals and our employees it became evident there was a necessity for an investment in capital and human resources to insure a reliable and flexible manufacturing source for radiochemical, radiopharmaceuticals and research isotopes with proximity to all major markets within the U.S. We hold ourselves, employees, clinical investigators, partner companies and management teams to the highest standards and business practices. NuView believes that strong corporate governance, innovative product development and great customer service are the cornerstones of our business.

We have now combined our corporate culture and the production capabilities at Trace. The Trace Linear Accelerator and Cyclotron technologies have large production and back up capabilities to provide the nuclear medicine community with pharmaceutical grade or radiochemical grade Tl-201, radiochemical grade I-123, In-111 and Cu-64. Please go to our product section for further product details and ordering information.